By a News Reporter-Staff News Editor at Gene Therapy Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventors Varney, Timothy (Baltimore, MD); Mills, Charles Randal (Finksburg, MD); Danilkovitch, Alla (Columbia, MD), filed on July 26, 2013, was made available online on February 6, 2014 (see also Pharmaceutical Companies). The assignee for this patent application is Osiris Therapeutics, Inc. Reporters obtained the following quote from the background information supplied by the inventors: "Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate readily into lineages including osteoblasts, myocytes, chondrocytes, and adipocytes (Pittenger, et al., Science, vol. 284, pg. 143 (1999); Haynesworth, et al., Bone, vol. 13, pg. 69 (1992); Prockop, Science, vol. 276, pg. 71 (1997)). In vitro studies have demonstrated the capability of MSCs to differentiate into muscle (Wakitani, et al., Muscle Nerve, vol. 18, pg. 1417 (1995)), neuronal-like precursors (Woodbury, et al., J. Neurosci. Res., Vol, 69. pg. 908 (2002); Sanchez-Ramos, et al., EXP. Neurol., vol. 171, pg. 109 (2001)), cardiomyocytes (Toma, et al., Circulation, vol. 105, pg. 93 (2002); Fakuda, Artif. Organs, vol. 25, pg. 187 (2001)) and possibly other cell types. In addition, MSCs have been … Continue reading →

This is a kind of approach I don't really support and I am very disappointed by the fact that it's so common: why do these bloggers fill the Internet with duplications of news articles? No one has written a single word of comment. I guess that isn't really useful (or perhaps for the Google spiders yes...). What I would like to do now and in the future is review interesting papers in the simplest way possible, leaving back stuff that's too geeky and adding here and there my personal opinions. I hope you will approve and enjoy this kind of approach. First of all: here is the complete reference. I just can't stand when the journalists write: "a group of researchers for the XYZ hospital..." - everyone who is interested in going more in depth should be given the opportunity to look at the original paper! Parekkadan B, van Poll D, Suganuma K, Carter EA, Berthiaume F, et al. (2007) Mesenchymal Stem Cell-Derived Molecules Reverse Fulminant Hepatic Failure. PLoS ONE 2/9 Human mesenchymal stem cells (MSCs) reside in the bone marrow next to the hematopoietic stem cells: they can differentiate in various cell types and have been shown to interact … Continue reading →

Boca Raton, FL (PRWEB) February 12, 2014 The Miami Stem Cell Treatment Center, PC, located in Miami, Ft. Lauderdale, and Boca Raton, Florida, announces a series of free public seminars on the use of stem cells for various degenerative and inflammatory conditions. They will be provided by Dr. Thomas A. Gionis, Surgeon-in-Chief, and, Dr. Nia Smyrniotis, Medical Director. The seminars will be held on February 16th and March 2nd. On February 16th, the seminar will be held at the Marriott Boca Raton, at Boca Center, 5150 Town Center Circle, Boca Raton, Florida 33486, at 2pm; and on March 2nd at the Hampton Inn Fort Lauderdale Downtown, 250 N. Andrews Blvd., Fort Lauderdale, Florida 33301, at 2pm. You can also join Miami Stem Cell Treatment Center at the Health and Wellness Experience Expo presented by WPEC Channel 12 and the Sun-Sentinel on March 1st at Mizner Park Amphitheater, Boca Raton, Florida from 10am-5pm. No reservations required. At the Miami Stem Cell Treatment Center, utilizing investigational protocols, adult adipose derived stem cells (ADSCs) can be deployed to improve patients quality of life with a number of degenerative conditions and diseases. ADSCs are taken from the patients own adipose (fat) tissue (also called … Continue reading →